Fidelis Care Hyperbaric Oxygen Therapy Prior Authorization Protocol

Fidelis Care's Clinical Criteria for HBOT

Fidelis Care, like other payers, establishes specific medical necessity criteria for HBOT, often aligning with national guidelines from organizations such as the Undersea and Hyperbaric Medical Society (UHMS) or evidence-based criteria sets like MCG Health or InterQual. Approved indications typically include diabetic foot ulcers (Wagner Grade 3 or higher), refractory osteomyelitis, radiation necrosis (osteoradionecrosis, soft tissue radionecrosis), compromised grafts/flaps, and gas gangrene. Documentation must clearly demonstrate the failure of conventional therapies, the specific diagnosis warranting HBOT, and the patient's overall medical stability for treatment.

Essential Documentation for HBOT Prior Authorization

A comprehensive PA request for Fidelis Care HBOT requires specific and detailed clinical documentation to support medical necessity. Insufficient or unclear documentation is a primary driver of delays and denials. This often includes detailed wound care notes, diagnostic imaging reports (e.g., X-rays, MRIs, CT scans), relevant laboratory results (e.g., A1C for diabetic patients), a comprehensive treatment plan outlining the proposed HBOT protocol (e.g., number of dives, pressure), and a clear attestation of prior failed conservative therapies. All submitted records must be current and reflect the patient's present condition.

CPT and ICD-10 Coding for Hyperbaric Oxygen Therapy

Accurate CPT and ICD-10 coding are foundational for successful Fidelis Care HBOT prior authorization. The primary CPT code for hyperbaric oxygen therapy is 99183, which covers the physician attendance and supervision of hyperbaric oxygen therapy, per session. Facility charges for the HBOT chamber and associated services are typically billed under specific HCPCS codes (e.g., G0277). Corresponding ICD-10 codes must precisely reflect the approved diagnosis for HBOT, such as E11.621 (Type 2 diabetes mellitus with diabetic foot ulcer) for diabetic foot ulcers, M86.6x (Other chronic osteomyelitis) for refractory osteomyelitis, or T86.81x (Complications of other specified internal prosthetic devices, implants and grafts) for compromised grafts. Mismatches between CPT, ICD-10, and clinical documentation will lead to PA rejection.

Fidelis Care Prior Authorization Submission Pathways

Fidelis Care offers multiple channels for prior authorization submission, each with varying levels of efficiency and integration potential. These typically include their proprietary provider portal, fax submission, and increasingly, electronic prior authorization (ePA) via X12 278 transactions. While fax remains an option, it is prone to manual errors and delays. The provider portal offers a more structured input method. For high-volume facilities, leveraging X12 278 through clearinghouses like Availity or integrated RCM systems can automate data transfer from EHRs like Epic Hyperspace or Cerner PowerChart, reducing manual data entry and improving turnaround times. Discussing X12 278 capabilities with your IT integration leads is essential.

Key Steps in the Fidelis Care HBOT PA Process

• Verify patient eligibility and benefits with Fidelis Care.
• Confirm the specific Fidelis Care medical policy for HBOT.
• Compile all required clinical documentation, ensuring it supports medical necessity.
• Accurately assign CPT and ICD-10 codes relevant to the HBOT indication.
• Submit the PA request via the most efficient available channel (e.g., X12 278, provider portal).
• Monitor the PA status regularly and document all communications.
• Prepare for potential peer-to-peer (P2P) review if the initial request is denied.

Managing Denials and the Peer-to-Peer Review Process

Despite meticulous preparation, Fidelis Care HBOT prior authorization requests may still face denial. Common reasons include insufficient documentation, lack of medical necessity per payer criteria, or incorrect coding. When a denial occurs, a structured appeals process is necessary. This often begins with a peer-to-peer (P2P) review, where the ordering physician or a designated clinical representative discusses the case with a Fidelis Care medical director. During a P2P, the physician must clearly articulate the clinical rationale, provide additional supporting evidence, and directly address the specific reasons for denial. Preparation for a P2P involves a thorough review of the patient's chart, the denial letter, and Fidelis Care's clinical policy.

Leveraging Technology for Prior Authorization Efficiency

Integrating technology into the prior authorization workflow can significantly enhance efficiency for Fidelis Care HBOT requests. ePA solutions, such as those offered by CoverMyMeds or through direct EHR integrations, can automate form filling, track submission status, and flag missing documentation. The adoption of industry standards like Da Vinci PAS (Prior Authorization Support) built on FHIR can facilitate real-time information exchange between providers and payers, moving towards a more automated and transparent PA process. Discussing SMART on FHIR capabilities with your IT integration leads is crucial for future-proofing your PA operations and reducing manual touches.